Precision Future: Decoding the Next Generation of Health Tech

Exploring the breakthroughs reshaping medicine through genomics, AI, and innovative therapies.

FR
Editor
Frank Reed
6 Total Articles
6 This Week
6.0 Avg per Week

About This Column

Frank Reed's 'Precision Future' delves into the rapidly evolving world of medical innovation and health technology. The column examines the groundbreaking advancements driving a new era of personalized medicine – from artificial intelligence-powered diagnostics and gene editing to next-generation sequencing and novel cell therapies. Reed expertly unpacks the science behind these breakthroughs, analyzing their potential impact on disease detection, treatment, and preventative care. He goes beyond the headlines, providing readers with a nuanced understanding of the challenges and opportunities facing the industry, including regulatory hurdles, investment trends, and clinical validation. 'Precision Future' is essential reading for those seeking to stay informed about the cutting edge of health tech and its potential to revolutionize healthcare as we know it. Frank’s insightful analysis connects the dots between research, investment, and patient outcomes, offering a clear and compelling vision of the future of medicine.

Recent Articles

Precision Future: Decoding the Next Generation of Health Tech 1 day ago

Standalone Vaccine Offers New Hope in Fight Against Resurgent Whooping Cough

European regulators endorse a novel pertussis vaccine, offering a targeted approach to bolster immunity and address waning protection against the highly contagious respiratory illness.

Read full article
Standalone Vaccine Offers New Hope in Fight Against Resurgent Whooping Cough
Precision Future: Decoding the Next Generation of Health Tech 1 day ago

Streamlining HPV Research: New Assay Promises Faster, More Accurate Results

Molecular Designs launches a new multiplex PCR panel designed to accelerate HPV research, offering improved efficiency and accuracy for scientists studying cancer prevention and treatment.

Read full article
Streamlining HPV Research: New Assay Promises Faster, More Accurate Results
Precision Future: Decoding the Next Generation of Health Tech 2 days ago

First Pertuzumab Biosimilar Approved, Promising Lower Costs for Breast Cancer Treatment

The FDA's approval of POHERDY marks a significant step forward in affordable cancer care, introducing the first biosimilar alternative to PERJETA for HER2-positive breast cancer patients.

Read full article
📰
Precision Future: Decoding the Next Generation of Health Tech 2 days ago

Biogen’s Higher-Dose Spinraza Faces FDA Setback Amid Competitive SMA Landscape

A promising higher dose of Biogen’s SMA therapy, Spinraza, hit a snag with the FDA, despite positive trial data. The company navigates a crowded market with rivals innovating gene therapies and oral treatments.

Read full article
Biogen’s Higher-Dose Spinraza Faces FDA Setback Amid Competitive SMA Landscape
Precision Future: Decoding the Next Generation of Health Tech 6 days ago

Epigenetic Age Tests Gain Traction – But Do the Results Stack Up?

Direct-to-consumer epigenetic testing is booming, promising insights into biological age and health risks. But experts raise questions about accuracy, interpretation, and whether the science truly delivers on its promises.

Read full article
📰
Precision Future: Decoding the Next Generation of Health Tech 6 days ago

Beyond Biological Clock: TruAge Test Promises Deeper Insights Into Aging—But Is It Worth the Cost?

A new direct-to-consumer epigenetic test aims to map aging at the organ level. We investigate the science, the cost, and the implications for the burgeoning longevity market.

Read full article
📰
UCID: 16